Lucie S.
- Country
- Czechia
- Department
- Department of Pediatric Hematology/Oncology
Research Overview
- Revumenib in Combination with Fludarabine and Cytarabine for Pediatric Refractory or Relapsed KMT2A-r, NUP98-r, or NPM1-mut Acute Myeloid Leukemia
- Phase 1b Study of the Safety and Pharmacokinetics of Pivekimab Sunirine in Pediatric Patients with Relapsed or Refractory CD123-Positive Acute Myeloid Leukemia
- International Pediatric Study of Arsenic Trioxide and Tretinoin ± Gemtuzumab Ozogamicin for Acute Promyelocytic Leukemia in Children and Adolescents
Data & Insights
Has run more than one trial at 152 of 238 partner sites.
Specializations
Pediatric Leukemia Treatment
This investigator specializes in treating acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in pediatric patients, with particular focus on high-risk and relapsed cases. Their research encompasses innovative therapeutic approaches for FLT3-mutated AML and CD22-positive B-cell precursor ALL.
- High-risk relapsed ALL management
- Novel therapeutic strategies for AML
- Targeted molecular therapies
The investigator works extensively with advanced treatment protocols for challenging pediatric leukemia cases.
Lymphoma Research
Their expertise extends to treating various lymphoma subtypes, particularly focusing on anaplastic large cell lymphoma (ALCL) and aggressive B-cell neoplasms. The investigator has significant experience in managing refractory cases using targeted therapies.
- B-cell lymphoma treatment
- ALK-positive lymphomas
- Refractory disease management
The research involves innovative approaches for treating resistant lymphoma cases in pediatric populations.
Solid Tumor Studies
The investigator conducts research on specific solid tumors, including inflammatory myofibroblastic tumors (IMT) and other rare pediatric malignancies. Their work includes evaluating targeted therapeutic approaches for ALK-positive solid tumors.
- Rare pediatric cancers
- Targeted molecular therapies
- Treatment resistance studies
The focus includes developing effective treatments for challenging and rare pediatric solid tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.